ClinicalTrials HQ

New York Medical College

New York Medical College

Explore linked clinical trials.

28 results ยท Page 1 of 2

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC AloneDNA Virus Infections, Herpesviridae infectious disease, Infections, adenoviridae infectious disease, cytomegalovirus infection, viral infectious diseaseRecruitingPhase 32026-09-11NCT07225972
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & LymphomaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmRecruitingPhase 12026-09-11NCT04972942
Targeted Ablation to Isolate Scar Channels Causing Ventricular TachycardiaArrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, cardiomyopathy, cardiovascular disorder, heart disorder, ventricular tachycardiaRecruitingNot stated2026-09-10NCT07814079
Virtual Tai Chi for Chronic Low Back Pain (Spine 2027)Back Pain, Low Back Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and SymptomsNot yet recruitingNot applicable2026-08-19NCT07772154
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaHemic and Lymphatic Diseases, Leukemia, Large Granular Lymphocytic, Neoplasms by Histologic Type, T-cell leukemia, T-cell non-Hodgkin lymphoma, aggressive NK-cell leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasmRecruitingEarly phase 12026-08-18NCT03719105
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell DiseaseCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell diseaseRecruitingPhase 22026-07-27NCT02675959
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphomaclassic Hodgkin lymphomaNot yet recruitingPhase 12026-05-20NCT07575893
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCLALK-positive anaplastic large cell lymphoma, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, anaplastic large cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 22026-05-20NCT07013565
CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphomaclassic Hodgkin lymphomaNot yet recruitingPhase 1 / Phase 22026-04-15NCT06617286
Defibrotide Dose-escalation for SOS Post-HSCTDigestive System Diseases, cardiovascular disorder, hepatic veno-occlusive disease, liver disorder, vascular disorderRecruitingPhase 22026-04-15NCT05987124
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin LymphomaB-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Hodgkins lymphoma, Infections, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Richter transformation, Tumor Virus Infections, diffuse large B-cell lymphoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, marginal zone lymphoma, neoplasm, viral infectious diseaseRecruitingPhase 1 / Phase 22026-04-15NCT04491370
Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic PurpuraCytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathyRecruitingPhase 12026-04-15NCT04323748
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS MalignanciesCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing sarcoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Urogenital Diseases, Urogenital Neoplasms, Wilms tumor, benign urinary system neoplasm, connective tissue neoplasm, epithelial neoplasm, hepatoblastoma, hereditary disease, hereditary neoplastic syndrome, kidney cancer, kidney disorder, mixed neoplasm, myomatous neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, osteosarcoma, primitive neuroectodermal tumor, rhabdomyosarcoma, sarcoma, urinary system disorderRecruitingPhase 12026-04-15NCT04308330
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infections, Primary Immunodeficiency Diseases, hereditary disease, immune system disorder, inborn error of immunity, viral infectious diseaseRecruitingPhase 1 / Phase 22026-04-15NCT04197596
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 DiseaseCOVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumoniaRecruitingPhase 1 / Phase 22026-04-13NCT04896606
CMV CTLs in Neonates With CMV InfectionPathologic Processes, Pathological Conditions, Signs and Symptoms, diseaseRecruitingPhase 22026-03-30NCT05564598
Improving Neck Control in Children With Cerebral Palsy Using RoboticsBrain Damage, Chronic, brain disorder, central nervous system disorder, cerebral palsy, nervous system disorderRecruitingNot applicable2025-09-09NCT06533293
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV InfectionCongenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Primary Immunodeficiency Diseases, Tumor Virus Infections, hereditary disease, immune system disorder, inborn error of immunity, viral infectious diseaseRecruitingPhase 22025-08-08NCT03266653
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Herpesviridae infectious disease, Infections, Primary Immunodeficiency Diseases, cytomegalovirus infection, hereditary disease, immune system disorder, inborn error of immunity, viral infectious diseaseRecruitingPhase 22025-08-08NCT03266640
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus InfectionCongenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Infections, Primary Immunodeficiency Diseases, adenoviridae infectious disease, hereditary disease, immune system disorder, inborn error of immunity, viral infectious diseaseRecruitingPhase 22025-08-08NCT03266627
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLB-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, diffuse large B-cell lymphoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma, viral infectious diseaseRecruitingPhase 22025-08-08NCT02393157
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell DiseaseCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell diseaseActive, not recruitingPhase 22025-08-08NCT01461837
Chemoradiotherapy With Targeted Immunotherapy in Pediatric LymphomaHemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphomaRecruitingPhase 22025-06-13NCT05253495
Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke SurvivorsNeurobehavioral Manifestations, Neurologic Manifestations, Paresis, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, aphasia, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, communication disorder, language disorder, nervous system disorder, speech disorder, stroke disorder, vascular disorderNot yet recruitingNot applicable2025-05-31NCT07000019
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT ChildrenHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myelodysplastic syndrome, myeloid leukemia, neoplasmEnrolling by invitationPhase 22025-05-04NCT02646839